A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan

Inclusion Criteria

• •1. Patients who received Zavicefta for the first time after the launch of Zavicefta
• •2. Patients who received Zavicefta for an infectious diseases indicated for Zavicefta
• •3. Patients with diagnosis of sepsis and/or renal impairment (creatinine clearance ≤ 50mL/min) at the start of the treatment with Zavicefta
• •4. Individuals who understand the nature of this study and give consent for the provision of the information collected in this study to third parties and the use of the information for other than intended use